Contact tracing could help avoid another lockdown. Can it work in the U.S.?

Contact tracing is an essential part of the plan to reopen the U.S. after the coronavirus lockdowns — but experts say the country will need more people, more money, and more cooperation than it has now.

The global pandemic through the eyes of the world’s children

This is life under lockdown, through the eyes of children. Their worries are matched in many places by resilience and hope, for a life beyond the coronavirus.

‘It doesn’t stay where you started’: Reopening some states heightens the risk of coronavirus surges in others

Reopening some states is "like having a peeing section in the swimming pool," as one public health official put it. The coronavirus "doesn’t stay where you started.”

Covid-19 testing issues could sink plans to re-open the country. Might CT scans help?

CT scans were widely used in China to identify #coronavirus cases, and their reliability there is fueling growing interest in using them in the U.S.

‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film

The physician and Pulitzer Prize-winning author tells STAT about how he and Ken Burns approached their new documentary, "The Gene: An Intimate History."

Explaining a mass quarantine: What does it mean to ‘shelter in place’? And who has the power to call for it?

In the U.S., a patchwork of local, state, and federal rules governs things like city-wide lockdowns and mass quarantines. Here's what can happen and what's legal and ethical.

Can you sue an algorithm for malpractice? It depends

Once a critical mass of radiologists use AI clinically, it could rapidly diffuse and, in a few years, reading chest x-rays, mammograms, head CTs, and other imaging without it will seem old-fashioned and dangerous.

Health care needs AI. It also needs the human touch

Will high-performing AI "clinicians" lead us to a less expensive and more accurate health care system that leaves human carers in the dust, relegated in their imperfections to simpler, lower-stakes tasks they can't mess up?

Pharmalittle: The inside story of an Ebola vaccine; fewer adults received opioid prescriptions

Dozens of drug makers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer.

Tech and health care need their own ‘Hippocratic oath’ to make digital health work

Companies working at the intersection of tech and health care need to change their ways before regulatory barriers and other problems set digital health back for years.

Pharmalittle: Drug factories ‘dump it down the drain’; breast cancer drug picked up by AstraZeneca shrinks tumors

A breast cancer drug acquired by AstraZeneca showed striking results when tested in women whose tumors tested positive for a marker called HER2.

‘Dump it down the drain’: How contaminants from prescription-drug factories pollute waterways

An investigation identified for the first time pharmaceutical companies whose factories are likely dumping substantial quantities of drugs into rivers and streams.

AI will revolutionize drug discovery — but only if experts are involved

To fruitfully apply AI to drug discovery, we need better feedback loops between developers and interdisciplinary teams that test the technology.

Smaller, lighter, cheaper: A serial entrepreneur wants his portable MRI to transform medicine

In a nondescript building in a Connecticut town sits a prototype that could change the way that doctors use MRIs.

New leaders needed to translate discoveries into patient care

To facilitate new discoveries, today's and tomorrow's leaders need to understand and navigate the languages and cultures of multiple sectors, from health care systems and academia to industry, finance, and government.

Biotech incubator LabCentral to double its space in Boston

LabCentral, the biotech incubator in Cambridge, Mass., that has nurtured dozens of startups in a shared working space, plans to roughly double in size in two years.

A new global initiative aims to use AI to improve public health in the developing world

A new effort, led by the Rockefeller Foundation, is aimed at delivering cutting-edge tech to parts of the world that have been slow to benefit from it — and improving public health in the process.

Artificial intelligence for medicine needs a Turing test. Obesity would be a good one

Demonstrating that artificial intelligence can create an effective alternative to weight-loss surgery would show the skeptics what medical AI can do. If it can't do this, it's time for medical AI to go home.

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

How patient records from one Boston hospital fueled an explosion in AI research in medicine

Patients’ de-identified medical records from one Boston hospital have become a crucial cog in a burgeoning field of artificial intelligence research.

‘Jumping genes’ could help CRISPR replace disease-causing DNA, study finds

A "jumping gene" might be harnessed to help CRISPR insert a string of healthy DNA in place of a disease-causing sequence.

Study highlights challenges in using artificial intelligence to personalize cancer treatment

A new study details the challenges of using natural language processing, a subtype of AI, to identify patients likely to respond to targeted cancer therapies.

Aim your baloney detector at the BS in health care

Health care has an acute BS problem. Just think of Theranos and IBM Watson. Thanks to social media, it can spread faster and farther than the truth.

Pharmalittle: Sanofi pledge to rebuild Notre Dame gets backlash; IBM halts AI product for drug development

Sanofi pledged about $11 million for rebuilding Notre Dame, but reaction has been mixed.

IBM halting sales of Watson AI tool for drug discovery amid sluggish growth

IBM is halting development and sales of its Watson artificial intelligence software to help pharmaceutical companies discover new treatments.

Paging Dr. Topol: Grasping the multidimensional narrative of ‘Deep Medicine’

The medical mind has limitations — a physician can know the signs of only a fraction of the 10,000 or so human diseases. Powerful tools like AI and machine learning can help transcend those limits.

Bristol-Myers Squibb turns to an AI startup to accelerate cancer research

Bristol-Myers Squibb, seeking to re-energize its cancer pipeline, is turning to an artificial intelligence startup, Concerto, to accelerate its clinical trials by using real-world data. $BMY

Peering inside life’s microworld: MIT’s 2019 image award winners

To honor advances in the visualization of biological processes, MIT's @kochinstitute sets up an annual exhibit in its lobby. Check out this year's selections:

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy